S. Rutz et al., Diagnostic and prognostic value of compound motor action potential of lower limbs in acute paraplegic patients, SPINAL CORD, 38(4), 2000, pp. 203-210
Objectives: To evaluate the diagnostic and prognostic contribution of motor
nerve conduction studies (NCS) in addition to neurological examination in
patients with acute paraplegia.
Methods: In 79 patients with acute onset of paraplegia due to traumatic or
ischaemic damage of the conus medullaris/cauda equina (conus/cauda) or lesi
on of the mid-thoracic spinal cord (epiconal) neurological (initial and fol
low-up clinical motor and sensory scores; outcome of ambulatory capacity de
termined at least 6 months post-trauma) and electrophysiological examinatio
ns (motor nerve conduction velocity (MNCV) and compound motor action potent
ial (CMAP) of tibial and peroneal nerves) were performed in parallel.
Results: Severe axonal motor neuropathies were significantly caused by conu
s/cauda lesions (loss of tibial CMAP in 71% and of peroneal CMAP in 68%) co
mpared to patients with epiconal lesion (no loss of tibial CMAP and abolish
ed peroneal CMAP in 14%). The CMAPs were deemed acutely pathological 4-14 d
ays post-trauma and were indicative of the severity of conus/cauda lesion w
hile the MNCV remained normal. Follow-up recordings (up to 1 year post trau
ma) revealed no significant change in the CMAP values. The clinical examina
tion according to the American Spinal Injury Association (ASIA protocol) in
contrast to the CMAP values was significantly related to the outcome of am
bulatory capacity.
Conclusions: In contrast to patients with an epiconal SCI almost all patien
ts with damage of the conus/cauda present a severe axonal neuropathy of the
tibial and peroneal nerves, Pathological CMAPs develop as early as 1-2 wee
ks after onset of acute paraplegia. They allow, at an early stage: to diffe
rentiate between conus/cauda or epiconal lesion and to assess the severity
of conus/cauda lesion. Thereafter follow-up examinations remain stable and
a developing worsening of peripheral nerve or spinal cord function: eg due
to post-traumatic syringomyelia, may be indicated by a secondary deteriorat
ion of CMAP values. The clinical examination, according to the ASIA protoco
l, in acute paraplegia patients, in contrast to the motor nerve conduction
studies, is of prognostic value in predicting the outcome of ambulatory cap
acity.